Tenaya Therapeutics, Inc.は2026年5月17日、TN-401遺伝子治療薬の第Ib/II相試験であるRIDGE-1の試験結果をまとめたスライド資料を公開した。本プレゼンテーションは、PKP2遺伝子関連不整脈源性右室心筋症に対する治療法に焦点を当てている。
当該スライド資料は、臨床データのレビューに関連して同社より発行された。NASDAQに銘柄コード「TNYA」で上場する同社の遺伝子治療候補薬に関する進行中の研究の詳細が記載されている。今回の発表資料には、新たな試験結果や参加者数に関する詳細は示されていない。
AIによるレポート AIによって生成された画像 事実確認済み
A single, under-the-skin dose of the investigational RNA-interference drug zilebesiran lowered blood pressure when added to standard therapy in adults whose hypertension remained uncontrolled, according to results from the global Phase 2 KARDIA-2 trial of 663 participants published in JAMA.
Inovio Pharmaceuticals held its first-quarter 2026 earnings call on May 13 to discuss financial results for the period ended March 31 and provide updates on its DNA medicines platform.
AIによるレポート
ProQR Therapeutics N.V. published its slide deck for a presentation at the TIDES USA 2026 conference. The materials were released on May 15, 2026, in connection with the company's Q1 earnings summary from May 12.
A new treatment called Daraxonrasib has shown strong results against advanced pancreatic cancer in a recent clinical trial. The drug targets a genetic mutation long considered impossible to treat effectively.
AIによるレポート
ARS Pharmaceuticals held its first quarter 2026 earnings conference call on May 15, highlighting early momentum in the new year. Company executives emphasized growth drivers including expanded access for its neffy product. The call featured forward-looking statements about the firm's commercial progress.
A needle-free, DNA-based vaccine candidate designed using machine-learning methods has completed a first-in-human Phase 1 study in the UK, with researchers reporting it was well tolerated and induced immune responses against multiple viruses in the sarbecovirus group, which includes SARS-CoV, SARS-CoV-2 and related bat coronaviruses.
AIによるレポート
Enhanced Group Inc. started trading on the NYSE in early May following its combination with Paradise Acquisition Corp. The telehealth firm focuses on peptides and performance-enhancing products.